About us
Medical Inventi S.A. is an innovative biotechnology company founded in 2015, created on the initiative of the academic community of the Medical University of Lublin and private capital. We specialise in the development and production of biomaterials that find applications in orthopaedics, dentistry and veterinary medicine.
Our products, available under the brand names FlexiOss®, FlexiOss®Dent and FlexiOss®Vet, are the result of many years of research trials and experience, and their effectiveness has been confirmed in numerous studies.

Medical Inventi. Improving Lives.

Our vision
To seek, develop and commercialise innovative solutions in the area of medical products and services aimed at improving the quality of life, in combination and cooperation with the scientific potential of Polish universities.

Our mission
Research and commercialisation of innovative solutions in the medical industry.
years of experience in biomaterials research
registered patents
procedures performed with FlexiOss® implants
foreign markets
Distribution markets
We are constantly expanding our distribution network, aiming to make our products available to as many patients and doctors as possible around the world. We are already present in the following markets:
Europe: Austria, Spain, Lithuania, Norway, Poland, Romania, Slovakia, Slovenia, Hungary, Italy, Greece
Asia: Philippines, Indonesia, Malaysia, Singapore, Vietnam, United Arab Emirates, Thailand, Iran
South America: Chile
Our history
Business scaling – entering new markets. Launch of R&D of two further products.
Signing of the first foreign contracts and the start of foreign sales. Establishment of cooperation with the first distributor in Poland.
Launch of three product brands: FlexiOss®, FlexiOss®Dent, FlexiOss®Vet.
Obtaining CE certification for FlexiOss® bone replacement composite. Obtaining ISO 13485:2016 certification. First commercial sale.
Successful completion of medical experiments with patients (5 cases in orthopaedics, 5 in dentistry).
Founding of Medical Inventi company.
Obtaining patent protection for the invention: Bioactive composite.
For investors
Investor relations aim to create and maintain effective communication between the Company and the investor community. The most important information for current and potential investors can be found here: